CLINICAL_TRIALS
trial_result
· 2014-12-10
Clinical Trial Update: Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer [Phase 2]
Summary
A Phase 2 trial evaluating erlotinib for stage III or stage IV pancreatic cancer was terminated; results were posted on 2014-12-10.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Roswell Park Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-12-10